Gianluca Bossi

7PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2024
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.

Valentina Piastra, Federica Ganci, Andrea Sacconi

|Feb 15, 2022
Dissection of the MKK3 Functions in Human Cancer: A Double-Edged Sword?

Valentina Piastra, Angelina Pranteda, Gianluca Bossi

|Apr 23, 2020
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments.

Angelina Pranteda, Valentina Piastra, Lorenzo Stramucci

|Dec 29, 2019
Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer.

Lorenzo Stramucci, Gianluca Bossi

|Nov 08, 2019
MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer.

Lorenzo Stramucci, Angelina Pranteda, Arianna Stravato

|Jan 20, 2019
Cytokine Modulation in Breast Cancer Patients Undergoing Radiotherapy: A Revision of the Most Recent Studies.

Raffaella Marconi, Annalisa Serafini, Anna Giovanetti

Pageof 2